NeuroAid II (MLC901) and polypharmacy in stroke and the risk of hepatotoxicity: a case report
Abstract Background NeuroAid II (MLC901) is a promising therapy for stroke patients who present outside of therapeutic window for reperfusion therapy. Studies have proven its efficacy in ischemic stroke; however, data of drug safety and combination with other medications especially anticoagulants ar...
Enregistré dans:
Auteurs principaux: | Anna Misya’il Abdul Rashid, Mohamad Syafeeq Faeez Md Noh, Abdul Hanif Khan Yusof Khan, Wei Chao Loh, Janudin Baharin, Azliza Ibrahim, Liyana Najwa Inche Mat, Wan Aliaa Wan Sulaiman, Fan Kee Hoo, Fazah Akhtar Hanapiah, Hamidon Basri |
---|---|
Format: | article |
Langue: | EN |
Publié: |
SpringerOpen
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8e2912eb01e540368284ee5b4ff77d01 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
High-frequency repetitive transcranial magnetic stimulation at dorsolateral prefrontal cortex for migraine prevention: A protocol for a systematic review of controlled trials.
par: Nabil Izzaatie Mohamad Safiai, et autres
Publié: (2021) -
Acta Nº901
par: Banco Central de Chile
Publié: (2019) -
Sustained-release nanoART formulation for the treatment of neuroAIDS
par: Jayant RD, et autres
Publié: (2015) -
Hot Deformation Behavior and Processing Map of GH901 Superalloy
par: Rui Ma, et autres
Publié: (2021) -
MLC601 in vascular dementia: an efficacy and safety pilot study
par: Pakdaman H, et autres
Publié: (2017)